tetano
Editor, Senior Moderator
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Aug 10;39(8):1045-1050. doi: 10.3760/cma.j.issn.0254-6450.2018.08.007.
[h=1][Current situation and related policies on the implementation and promotion of influenza vaccination, in China].[/h] [Article in Chinese; Abstract available in Chinese from the publisher]
Peng ZB[SUP]1[/SUP], Wang DY[SUP]2[/SUP], Yang J[SUP]3[/SUP], Yang P[SUP]4[/SUP], Zhang YY[SUP]5[/SUP], Chen J[SUP]6[/SUP], Chen T[SUP]2[/SUP], Zheng YM[SUP]1[/SUP], Zheng JD[SUP]1[/SUP], Jiang SQ[SUP]7[/SUP], Xu LL[SUP]8[/SUP], Kang M[SUP]9[/SUP], Qin Y[SUP]1[/SUP], Zhao MJ[SUP]1[/SUP], Li ZJ[SUP]1[/SUP], Feng LZ[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] in English, Chinese
Influenza can be prevented through annual appropriate vaccination against the virus concerned. In China, influenza vaccine is categorized as "Class Ⅱ" infectious diseases which the cost is paid out of the user's pockets. The annual coverage of influenza vaccination had been 2%-3%. The main reasons for the low coverage would include the following factors: lacking awareness on both the disease and vaccine, poor accessibility of vaccination service, and the cost of vaccination. To reduce the health and economic burden associated with influenza, comprehensive policies should be improved, targeting the coverage of seasonal influenza vaccination. These items would include: ① Different financing reimbursement schemes and mechanisms to improve the aspiration on vaccination and on the vaccine coverage in high-risk groups, as young children, elderly, people with underlying medical conditions; ② to ameliorate equality of vaccination services; ③ to improve knowledge of the health care workers (HCWs) and the public on influenza and related vaccines; ④ to improve clinical and preventive medical practice and vaccination among HCWs through revising clinical guidelines, pathway and consensus of experts; ⑤ to provide more convenient, accessible and normative vaccination service system; ⑥ to strengthen research and development as well as marketing on novel influenza vaccines; ⑦ to revise items regarding the contraindication for influenza vaccine on pregnancy women, stated in the Chinese Pharmacopoeia.
[h=4]KEYWORDS:[/h] Influenza vaccine; Policy considerations; Promotion; Vaccination
PMID: 30180426
[h=1][Current situation and related policies on the implementation and promotion of influenza vaccination, in China].[/h] [Article in Chinese; Abstract available in Chinese from the publisher]
Peng ZB[SUP]1[/SUP], Wang DY[SUP]2[/SUP], Yang J[SUP]3[/SUP], Yang P[SUP]4[/SUP], Zhang YY[SUP]5[/SUP], Chen J[SUP]6[/SUP], Chen T[SUP]2[/SUP], Zheng YM[SUP]1[/SUP], Zheng JD[SUP]1[/SUP], Jiang SQ[SUP]7[/SUP], Xu LL[SUP]8[/SUP], Kang M[SUP]9[/SUP], Qin Y[SUP]1[/SUP], Zhao MJ[SUP]1[/SUP], Li ZJ[SUP]1[/SUP], Feng LZ[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] in English, Chinese
Influenza can be prevented through annual appropriate vaccination against the virus concerned. In China, influenza vaccine is categorized as "Class Ⅱ" infectious diseases which the cost is paid out of the user's pockets. The annual coverage of influenza vaccination had been 2%-3%. The main reasons for the low coverage would include the following factors: lacking awareness on both the disease and vaccine, poor accessibility of vaccination service, and the cost of vaccination. To reduce the health and economic burden associated with influenza, comprehensive policies should be improved, targeting the coverage of seasonal influenza vaccination. These items would include: ① Different financing reimbursement schemes and mechanisms to improve the aspiration on vaccination and on the vaccine coverage in high-risk groups, as young children, elderly, people with underlying medical conditions; ② to ameliorate equality of vaccination services; ③ to improve knowledge of the health care workers (HCWs) and the public on influenza and related vaccines; ④ to improve clinical and preventive medical practice and vaccination among HCWs through revising clinical guidelines, pathway and consensus of experts; ⑤ to provide more convenient, accessible and normative vaccination service system; ⑥ to strengthen research and development as well as marketing on novel influenza vaccines; ⑦ to revise items regarding the contraindication for influenza vaccine on pregnancy women, stated in the Chinese Pharmacopoeia.
[h=4]KEYWORDS:[/h] Influenza vaccine; Policy considerations; Promotion; Vaccination
PMID: 30180426